113 related articles for article (PubMed ID: 38262868)
1. The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
Gregg JR; Magill R; Fang AM; Chapin BF; Davis JW; Adibi M; Chéry L; Papadopoulos J; Pettaway C; Pisters L; Ward JF; Hahn AW; Daniel CR; Bhaskaran J; Zhu K; Guerrero M; Zhang M; Troncoso P
Urol Oncol; 2024 Apr; 42(4):116.e1-116.e7. PubMed ID: 38262868
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
3. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract][Full Text] [Related]
5. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
6. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB
Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
[TBL] [Abstract][Full Text] [Related]
7. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
8. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.
Onder AU; Yaycioglu O; Ataus S; Gul U; Demirkesen O; Yalcin V; Solok V
Int J Urol; 2003 Jun; 10(6):302-6; discussion 307-8. PubMed ID: 12757598
[TBL] [Abstract][Full Text] [Related]
9. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract][Full Text] [Related]
10. The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy.
Mandel P; Kretschmer A; Chandrasekar T; Nguyen HG; Buchner A; Stief CG; Tilki D
Urol Oncol; 2014 Apr; 32(3):297-302. PubMed ID: 24332640
[TBL] [Abstract][Full Text] [Related]
11. Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.
Goris Gbenou MC; Peltier A; Schulman CC; Velthoven Rv
Urol Oncol; 2016 Jun; 34(6):254.e1-6. PubMed ID: 26822075
[TBL] [Abstract][Full Text] [Related]
12. Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort.
Fine SW; Al-Ahmadie HA; Vertosick E; Vickers AJ; Chen YB; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE
Urol Pract; 2022 Sep; 9(5):459-465. PubMed ID: 37145713
[TBL] [Abstract][Full Text] [Related]
13. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
[TBL] [Abstract][Full Text] [Related]
14. Reliable identification of transition zone prostatic adenocarcinoma in preoperative needle core biopsy.
Lee S; Walsh S; Woods CG; Bonkhoff H; Cohen RJ
Hum Pathol; 2013 Oct; 44(10):2331-7. PubMed ID: 23954139
[TBL] [Abstract][Full Text] [Related]
15. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy.
Al-Ahmadie HA; Tickoo SK; Olgac S; Gopalan A; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Feb; 32(2):229-35. PubMed ID: 18223325
[TBL] [Abstract][Full Text] [Related]
16. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
Steuber T; Karakiewicz PI; Augustin H; Erbersdobler A; Lange I; Haese A; Chun KH; Walz J; Graefen M; Huland H
J Urol; 2005 Mar; 173(3):737-41. PubMed ID: 15711259
[TBL] [Abstract][Full Text] [Related]
17. Development and internal validation of preoperative transition zone prostate cancer nomogram.
Steuber T; Chun FK; Erbersdobler A; Briganti A; Haese A; Graefen M; Schlomm T; Valiquette L; Huland H; Karakiewicz PI
Urology; 2006 Dec; 68(6):1295-300. PubMed ID: 17141836
[TBL] [Abstract][Full Text] [Related]
18. Biologic differences between peripheral and transition zone prostate cancer.
Lee JJ; Thomas IC; Nolley R; Ferrari M; Brooks JD; Leppert JT
Prostate; 2015 Feb; 75(2):183-90. PubMed ID: 25327466
[TBL] [Abstract][Full Text] [Related]
19. Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.
Lee H; Hwang SI; Lee HJ; Byun SS; Lee SE; Hong SK
PLoS One; 2018; 13(6):e0199636. PubMed ID: 29933396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
